<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Conversational no-code and multi-agentic disease module identification and drug repurposing prediction with ChatDRex - Health AI Hub</title>
    <meta name="description" content="ChatDRex is a novel conversational, multi-agent AI system designed to democratize network-based drug repurposing prediction by enabling non-expert researchers t">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Conversational no-code and multi-agentic disease module identification and drug repurposing prediction with ChatDRex</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.21438v1" target="_blank">2511.21438v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-26
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Simon S√ºwer, Kester Bagemihl, Sylvie Baier, Lucia Dicunta, Markus List, Jan Baumbach, Andreas Maier, Fernando M. Delgado-Chaves
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.AI, cs.MA
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.21438v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.21438v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">ChatDRex is a novel conversational, multi-agent AI system designed to democratize network-based drug repurposing prediction by enabling non-expert researchers to control complex bioinformatic analyses using natural language. It integrates an extensive biomedical knowledge graph (NeDRex) with specialized bioinformatics agents for tasks ranging from data retrieval and algorithm execution to functional evaluation, literature mining, and scientific discussion, all while incorporating a reasoning module for user engagement and hallucination detection.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This system significantly impacts medical research by streamlining the drug repurposing process, making advanced bioinformatics tools accessible to a broader range of clinical and biological experts, thereby accelerating the discovery of new treatments and advancing personalized medicine.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>ChatDRex is a conversational, multi-agent AI system designed to assist physicians and researchers in identifying disease modules and predicting drug repurposing candidates. It provides natural language access to complex bioinformatics analyses and a biomedical knowledge graph, enabling clinical experts without computer science expertise to generate hypotheses and explore new therapeutic opportunities, thereby accelerating drug discovery and advancing personalized medicine.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the challenge of in silico drug repurposing prediction, which traditionally requires fragmented, specialized tools and expertise across multiple domains (pharmacology, medicine, biology, bioinformatics) and struggles with heterogeneous data.</li>
                    
                    <li>Introduces ChatDRex, a conversational, multi-agent system built upon the integrated systems medicine knowledge graph NeDRex, providing natural language access to complex biomedical data and analytical workflows.</li>
                    
                    <li>Features a flexible multi-agent design with specialized agents for query routing, data retrieval, network analysis (disease module identification, drug repurposing), functional coherence evaluation (in silico validation), literature mining, and scientific discussion.</li>
                    
                    <li>Incorporates a dedicated reasoning module to keep the user actively involved in the analytical process, serving to clarify results and enable detection of potential AI hallucinations, enhancing reliability and interpretability.</li>
                    
                    <li>Democratizes access to advanced bioinformatics, allowing physicians and researchers without computer science expertise to execute complex analyses and generate hypotheses for drug repurposing candidates.</li>
                    
                    <li>Aims to accelerate the discovery of novel therapies, advance personalized medicine, and foster translational research by enabling clinical experts to explore drug repurposing opportunities more efficiently.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>ChatDRex employs a conversational, multi-agent AI architecture. It leverages the NeDRex integrated systems medicine knowledge graph for extensive biomedical data access. Specialized agents are designed for specific tasks: natural language query processing, data retrieval from the KG, execution of bioinformatics algorithms (e.g., network analysis for disease module identification and drug repurposing prediction), functional evaluation of results, literature mining, and scientific contextualization. A reasoning module ensures user involvement and helps detect AI hallucinations.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The paper presents the design and capabilities of ChatDRex, demonstrating its ability to facilitate complex bioinformatic analyses for network-based drug repurposing through a user-friendly conversational interface. It highlights the successful integration of diverse specialized agents, a comprehensive knowledge graph, and a user-in-the-loop reasoning module, effectively democratizing access to advanced computational drug discovery methods for non-computer science experts.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>ChatDRex has the potential to significantly accelerate the identification of promising drug repurposing candidates by enabling clinicians and medical researchers to directly generate and validate hypotheses. This could lead to faster development of novel therapies, more cost-effective drug development, and improved personalized treatment strategies by leveraging existing drugs for new indications.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>While the system includes a dedicated reasoning module for 'hallucination detection,' this implies that generative AI components may still produce incorrect or misleading information, requiring active user oversight ('keeping the user in the loop') for validation and accuracy. The abstract doesn't detail the scope or current success rate of this detection or the specific limitations of the underlying NeDRex KG or the integrated algorithms.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly state future research directions for ChatDRex itself, but rather its anticipated impact. It implies ongoing development in accelerating novel therapy discovery, advancing personalized medicine, and enhancing translational research by making such tools more accessible.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Clinical Medicine</span>
                    
                    <span class="tag">Systems Biology</span>
                    
                    <span class="tag">Bioinformatics</span>
                    
                    <span class="tag">Drug Discovery and Development</span>
                    
                    <span class="tag">Personalized Medicine</span>
                    
                    <span class="tag">Translational Research</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Drug Repurposing</span>
                    
                    <span class="tag tag-keyword">Multi-agent Systems</span>
                    
                    <span class="tag tag-keyword">Conversational AI</span>
                    
                    <span class="tag tag-keyword">Knowledge Graph</span>
                    
                    <span class="tag tag-keyword">Bioinformatics</span>
                    
                    <span class="tag tag-keyword">Network Analysis</span>
                    
                    <span class="tag tag-keyword">Personalized Medicine</span>
                    
                    <span class="tag tag-keyword">Natural Language Processing</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Repurposing approved drugs offers a time-efficient and cost-effective alternative to traditional drug development. However, in silico prediction of repurposing candidates is challenging and requires the effective collaboration of specialists in various fields, including pharmacology, medicine, biology, and bioinformatics. Fragmented, specialized algorithms and tools often address only narrow aspects of the overall problem, and heterogeneous, unstructured data landscapes require specialized users to be involved. Hence, these data services do not integrate smoothly across workflows. With ChatDRex, we present a conversation-based, multi-agent system that facilitates the execution of complex bioinformatic analyses aiming for network-based drug repurposing prediction. It builds on the integrated systems medicine knowledge graph NeDRex. ChatDRex provides natural language access to its extensive biomedical KG and integrates bioinformatics agents for network analysis and drug repurposing, complemented by agents for functional coherence evaluation for in silico validation, as well as agents for literature mining and for discussing the obtained results in a scientific context. Its flexible multi-agent design assigns specific tasks to specialized agents, including query routing, data retrieval, algorithm execution, and result visualization. A dedicated reasoning module keeps the user in the loop and allows for hallucination detection. By enabling physicians and researchers without computer science expertise to control complex analyses in natural language, ChatDRex democratizes access to bioinformatics as an important resource for drug repurposing. It enables clinical experts to generate hypotheses and explore drug repurposing opportunities, ultimately accelerating the discovery of novel therapies and advancing personalized medicine and translational research.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>